David S. Romeo

Array ( [id] => 7800664 [patent_doc_number] => 08128934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Method for treatment or prevention of disease associated with functional disorder of regulatory T cell' [patent_app_type] => utility [patent_app_number] => 12/084907 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 20347 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128934.pdf [firstpage_image] =>[orig_patent_app_number] => 12084907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734352 [patent_doc_number] => 20080051332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'METHOD OF MODULATING HEMATOPOIETIC STEM CELLS AND TREATING HEMATOLOGIC DISEASES USING INTRANASAL PARATHYROID HORMONE' [patent_app_type] => utility [patent_app_number] => 11/559276 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24162 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051332.pdf [firstpage_image] =>[orig_patent_app_number] => 11559276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479195 [patent_doc_number] => 20100092468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'METHOD FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO TNF-ALPHA BLOCKING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/513738 [patent_app_country] => US [patent_app_date] => 2006-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092468.pdf [firstpage_image] =>[orig_patent_app_number] => 12513738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5226878 [patent_doc_number] => 20070256145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'MAMMALIAN TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 11/557689 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20956 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20070256145.pdf [firstpage_image] =>[orig_patent_app_number] => 11557689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182645 [patent_doc_number] => 20070053991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Cartilage-derived morphogenetic proteins' [patent_app_type] => utility [patent_app_number] => 11/592811 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9830 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053991.pdf [firstpage_image] =>[orig_patent_app_number] => 11592811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9232344 [patent_doc_number] => 08597646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders' [patent_app_type] => utility [patent_app_number] => 12/084098 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 89 [patent_no_of_words] => 21388 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12084098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999831 [patent_doc_number] => 20070042465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'MAMMALIAN TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 11/548052 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20895 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042465.pdf [firstpage_image] =>[orig_patent_app_number] => 11548052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148767 [patent_doc_number] => 20070048827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'MAMMALIAN TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 11/548028 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20894 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048827.pdf [firstpage_image] =>[orig_patent_app_number] => 11548028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999838 [patent_doc_number] => 20070042472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'MAMMALIAN TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 11/548063 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20895 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042472.pdf [firstpage_image] =>[orig_patent_app_number] => 11548063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000577 [patent_doc_number] => 20070043211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'MAMMALIAN TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 11/548072 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20892 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043211.pdf [firstpage_image] =>[orig_patent_app_number] => 11548072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149680 [patent_doc_number] => 20070049740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'MAMMALIAN TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 11/548037 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20893 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049740.pdf [firstpage_image] =>[orig_patent_app_number] => 11548037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204337 [patent_doc_number] => 07629146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Truncated 24kDa basic fibroblast growth factor' [patent_app_type] => utility [patent_app_number] => 11/544970 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 7356 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629146.pdf [firstpage_image] =>[orig_patent_app_number] => 11544970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034706 [patent_doc_number] => 20070099245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'ASSAYS FOR NEUTRALIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/537178 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10689 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099245.pdf [firstpage_image] =>[orig_patent_app_number] => 11537178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501676 [patent_doc_number] => 20090162364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Apo-2 ligand' [patent_app_type] => utility [patent_app_number] => 11/529083 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21017 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162364.pdf [firstpage_image] =>[orig_patent_app_number] => 11529083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182616 [patent_doc_number] => 20070053962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Diagnostic markers of wound infection III' [patent_app_type] => utility [patent_app_number] => 11/516212 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6158 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053962.pdf [firstpage_image] =>[orig_patent_app_number] => 11516212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107934 [patent_doc_number] => 20070066812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Fibroblast growth factor homologous factor-2 and methods of use' [patent_app_type] => utility [patent_app_number] => 11/514821 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9493 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066812.pdf [firstpage_image] =>[orig_patent_app_number] => 11514821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8176172 [patent_doc_number] => 08178083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Treatment of optic neuritis' [patent_app_type] => utility [patent_app_number] => 11/991026 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9146 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178083.pdf [firstpage_image] =>[orig_patent_app_number] => 11991026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688282 [patent_doc_number] => 20060286597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Aortic carboxypeptidase-like polypeptide' [patent_app_type] => utility [patent_app_number] => 11/507811 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9065 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286597.pdf [firstpage_image] =>[orig_patent_app_number] => 11507811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720081 [patent_doc_number] => 20080242604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Human Nodal and Lefty Homologues' [patent_app_type] => utility [patent_app_number] => 11/466004 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 53375 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242604.pdf [firstpage_image] =>[orig_patent_app_number] => 11466004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189065 [patent_doc_number] => 20070167374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)' [patent_app_type] => utility [patent_app_number] => 11/504535 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7200 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167374.pdf [firstpage_image] =>[orig_patent_app_number] => 11504535 [rel_patent_id] =>[rel_patent_doc_number] =>)